Product Information
FENOFIBRATE 145 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.1131 per EA under NDC 69315028809. Its NADAC has been published 139 times since Feb 8, 2023.
Strength
145 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315028809
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211122On Market Since
7/18/2022
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 145 MG TABLET has been published 139 times since Feb 8, 2023, and over the history we have for it it has declined 19.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1131 per EA |
|---|---|
| All-time high | $0.1605 (Oct 11, 2023) |
| All-time low | $0.1088 (Nov 20, 2024) |
| 52-week high | $0.1348 |
| 52-week low | $0.1131 |
| Median price | $0.1370 |
| Average price | $0.1373 |
| Largest weekly change | +24.3% (Nov 22, 2023) |
| Weeks tracked | 139 |
| Tracking since | Feb 8, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 145 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 145 MG TABLET, manufactured by Leading Pharma, LLC, is $0.1131 per EA (NDC 69315028809), effective Oct 1, 2025.
How has the price of FENOFIBRATE 145 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 145 MG TABLET has declined 19.6%. It has been tracked across 139 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 145 MG TABLET?
Since Feb 8, 2023, the NADAC for FENOFIBRATE 145 MG TABLET has ranged from a low of $0.1088 (Nov 20, 2024) to a high of $0.1605 (Oct 11, 2023), with a median of $0.1370 per EA.
Are there cheaper alternatives to FENOFIBRATE 145 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as FENOFIBRATE 145 MG TABLET, but none are currently priced below it.
Who manufactures FENOFIBRATE 145 MG TABLET?
FENOFIBRATE 145 MG TABLET (NDC 69315028809) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification